Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R N Tamura

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|February 1, 1991
Comparison of the immunogenicity of recombinant and pituitary human growth hormone in rhesus monkeysC M Zwickl, K S Cocke, R N Tamura, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|September 15, 2010
Comparative toxicity of oral cephalosporin antibiotics in the rabbit and in a rabbit kidney cell line (LLC-RK(1))P D Williams, M K Buening, C L Gries, et al.
The American Journal of Psychiatry|November 13, 1998
Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study GroupD Michelson, R B Lydiard, M H Pollack, et al.
The American Journal of Psychiatry|April 1, 1997
Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trialG D Tollefson, C M Beasley, P V Tran, et al.
Methods in Enzymology|January 1, 1994
Role of transforming growth factor beta and decorin in controlling fibrosisJ R Harper, R C Spiro, W A Gaarde, et al.
The Journal of Clinical Psychiatry|July 13, 1999
Changes in adverse events reported by patients during 6 months of fluoxetine therapyJ Zajecka, J D Amsterdam, F M Quitkin, et al.
European Journal of Clinical Nutrition|September 14, 2017
Vitamin D and probiotics supplement use in young children with genetic risk for type 1 diabetesJ Yang, R N Tamura, U M Uusitalo, et al.
Archives of General Psychiatry|October 4, 2000
Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study GroupJ S Street, W S Clark, K S Gannon, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|February 1, 1991
Comparison of the immunogenicity of recombinant and pituitary human growth hormone in rhesus monkeysC M Zwickl, K S Cocke, R N Tamura, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|September 15, 2010
Comparative toxicity of oral cephalosporin antibiotics in the rabbit and in a rabbit kidney cell line (LLC-RK(1))P D Williams, M K Buening, C L Gries, et al.
The American Journal of Psychiatry|November 13, 1998
Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study GroupD Michelson, R B Lydiard, M H Pollack, et al.
The American Journal of Psychiatry|April 1, 1997
Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trialG D Tollefson, C M Beasley, P V Tran, et al.
Methods in Enzymology|January 1, 1994
Role of transforming growth factor beta and decorin in controlling fibrosisJ R Harper, R C Spiro, W A Gaarde, et al.
The Journal of Clinical Psychiatry|July 13, 1999
Changes in adverse events reported by patients during 6 months of fluoxetine therapyJ Zajecka, J D Amsterdam, F M Quitkin, et al.
European Journal of Clinical Nutrition|September 14, 2017
Vitamin D and probiotics supplement use in young children with genetic risk for type 1 diabetesJ Yang, R N Tamura, U M Uusitalo, et al.
Archives of General Psychiatry|October 4, 2000
Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study GroupJ S Street, W S Clark, K S Gannon, et al.
Pageof 4